Filing Details

Accession Number:
0001384101-21-000180
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-12-08 16:42:10
Reporting Period:
2021-12-06
Accepted Time:
2021-12-08 16:42:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1384101 Veracyte Inc. VCYT Services-Medical Laboratories (8071) 205455398
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1769333 C Giulia Kennedy 6000 Shoreline Court
Suite 300
South San Francisco CA 94080
Chief Scientific & Med Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-12-06 4,406 $5.98 53,394 No 4 M Direct
Common Stock Acquisiton 2021-12-06 3,750 $20.21 57,144 No 4 M Direct
Common Stock Disposition 2021-12-06 3,550 $35.37 53,594 No 4 S Direct
Common Stock Disposition 2021-12-06 3,897 $36.11 49,697 No 4 S Direct
Common Stock Disposition 2021-12-06 1,785 $37.26 47,912 No 4 S Direct
Common Stock Acquisiton 2021-12-07 4,375 $24.69 52,287 No 4 M Direct
Common Stock Acquisiton 2021-12-07 1,750 $26.55 54,037 No 4 M Direct
Common Stock Disposition 2021-12-07 4,375 $39.69 49,662 No 4 S Direct
Common Stock Disposition 2021-12-07 1,750 $41.55 47,912 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2021-12-06 4,406 $0.00 4,406 $5.98
Common Stock Stock Option (right to buy) Disposition 2021-12-06 3,750 $0.00 3,750 $20.21
Common Stock Stock Option (right to buy) Disposition 2021-12-07 4,375 $24.69 4,375 $24.69
Common Stock Stock Option (right to buy) Disposition 2021-12-07 1,750 $26.55 1,750 $26.55
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
4,407 2028-03-01 No 4 M Direct
18,750 2029-02-27 No 4 M Direct
39,375 2030-03-27 No 4 M Direct
0 2030-05-10 No 4 M Direct
Footnotes
  1. The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 11, 2021.
  2. Represents weighted average sales price. Sale prices for the transactions range from $34.70 to $35.70. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
  3. Represents weighted average sales price. Sale prices for the transactions range from $35.79 to $36.74. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
  4. Represents weighted average sales price. Sale prices for the transactions range from $36.88 to $37.66. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
  5. The option becomes exercisable as to 25% of the shares on March 2, 2019, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.
  6. The option becomes exercisable as to 25% of the shares on February 28, 2020, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.
  7. The option becomes exercisable as to 25% of the shares on February 28, 2021, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuousservice thereafter.
  8. The option is fully vested.